The Dxcover platform combines novel hardware with artificial intelligence algorithms to analyse a patient's blood and detect the presence or absence of disease. Their goal is to be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
- Investment status Current
- Invested 2019
- Category Health & Life Sciences